Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Brain tissue phospholipid incorporation refers to the metabolic and cellular processes through which phospholipids, derived from dietary, peripheral, or endogenous sources, are synthesized, remodeled, and integrated into the membranes of brain cells. This process is critical for maintaining the unique structure and fluidity of neuronal and glial membranes, thus affecting synaptic plasticity, neurotransmission, cell signaling, and energy metabolism[1][3][4][5]. Key pathways include both de novo biosynthesis and remodeling of phospholipids (e.g., phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine), with numerous enzymes facilitating acyl chain incorporation and head group exchange (e.g. GPATs, AGPATs, LPCATs, PLA2, ABHDs)[3]. Alterations in brain phospholipid incorporation are implicated in a range of diseases, notably Alzheimer’s disease, other neurodegenerative conditions, inflammatory states, and metabolic syndromes[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain tissue phospholipid incorporation.